Blood Loss, Dysfunctional Labor, Uterine Atony
Conditions
Brief summary
The objective of the study is to demonstrate whether cooling the uterine smooth muscle during cesarean section (following delivery of the fetus) will promote better uterine contraction and involution resulting in lower blood loss, use of fewer uterotonic medications, and fewer hysterectomies following cesarean section for dysfunctional labor.
Detailed description
Two hundred patients will be drawn from all pregnant women who require a cesarean delivery for dysfunctional labor. Dysfunctional labor will be defined as cervical dilation of 3 or more centimeters, in active labor without cervical change for 2 or more hours. Patients will be randomly assigned to the study group or the control group, and each group will have 100 patients. Following the delivery of the fetus, patients in the control group will have IV Pitocin administered per the usual protocol and the uterus will be wrapped in lab sponges soaked in room-temperature saline while the uterine incision is closed per the attending obstetrician's usual practice. Additional utero-tonic medications may be given to improve uterine contraction. In the study group, following the delivery of the fetus, the uterus will be externalized in the usual fashion, except the uterus will be wrapped with lap sponges saturated in sterile, iced normal saline. Additional utero-tonic medications may also be given in the study group to improve uterine contraction. Immediately after the delivery of the fetus and prior to the delivery of the placenta, the amniotic fluid and blood on the surgical field will be aspirated into the suction canister. This amount of fluid in the suction canister will be noted and subtracted from the amount of fluid in the canister at the conclusion of the surgery. At the conclusion of the surgery, blood loss will be calculated by measuring the content of blood in the suction canister, and by weighing the surgical sponges. Post surgical vaginal bleeding will be monitored and calculated until the patient is discharged from the labor and delivery unit. Use of utero-tonic medications will be recorded. At the conclusion of the study, the amount of blood loss and utero-tonic drugs between the control and study groups will be compared. The need for additional surgeries, such as a hysterectomy or D&C, will be compared between the two groups.
Interventions
OTHERCold laparotomy sponges
Cold laparotomy sponges are lap sponges that are saturated in sterile, iced normal saline
DRUGPitocin
Pitocin is administered intravenously according to the usual protocol.
Sponsors
Baylor Research Institute
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* pregnant women of any age * gravidity and gestational duration who present for cesarean section and who have given informed consent to be in the study.
Exclusion criteria
* Women who refuse to be in the study * women who are unable to consent due to emergent nature of the cesarean section * women who are unable to understand the nature of the study due to mental illness, mental retardation, medical condition, or other communication barrier will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Estimated Blood Loss | up to 24 hours after surgery |
Secondary
| Measure | Time frame |
|---|---|
| Change in Hematocrit | up to 24 hours after surgery |
| Need for use of uterotonic medications | during cesarean section |
Contacts
PRINCIPAL_INVESTIGATORJack Stecher, MD
BUMC Labor and Delivery
Outcome results
None listed